[Studies on xipamide (4-chlor-5-sulfamoyl-2',6'-salicyloxylidide). Part II. Pharmacokinetics in man].
D000284:Administration, Oral; D004232:Diuretics / Q000378:metabolism*; D005243:Feces / Q000032:analysis; D005965:Glucuronates / Q000378:metabolism; D006801:Humans; D007275:Injections, Intravenous; D007674:Kidney Diseases / Q000378:metabolism; D007700:Kinetics; D006435:Renal Dialysis; D013462:Sulfur Radioisotopes; D013997:Time Factors; D014988:Xipamide / Q000008:administration & dosage / Q000378:metabolism*
D004232:Diuretics; D005965:Glucuronates; D013462:Sulfur Radioisotopes; D014988:Xipamide
Untersuchungen mit Xipamid (4-Chlor-5-sulfamoyl-2',6'-salicyloxylidid). Teil II: Pharmakokinetik beim Menschen.